Successfully treated spondylodiscitis due to a previously unreported mycobacterium

J Med Microbiol. 2006 Jan;55(Pt 1):119-121. doi: 10.1099/jmm.0.46256-0.

Abstract

A non-tuberculous mycobacterium was isolated, following a vertebral needle aspiration, from the blood of a patient with severe spondylodiscitis. The strain turned out to be different from any known mycobacterial species and was quite drug-susceptible in vitro. The patient improved markedly following treatment with meropenem, clarithromycin and amikacin.

Publication types

  • Case Reports

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Base Sequence
  • DNA, Ribosomal Spacer / analysis
  • Discitis / drug therapy*
  • Discitis / microbiology*
  • Genes, rRNA
  • Humans
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Mycobacterium / classification
  • Mycobacterium / drug effects*
  • Mycobacterium / genetics
  • Mycobacterium / isolation & purification*
  • Mycobacterium Infections / drug therapy
  • Mycobacterium Infections / microbiology
  • RNA, Ribosomal, 16S / genetics
  • RNA, Ribosomal, 23S / genetics
  • Sequence Analysis, DNA
  • Treatment Outcome

Substances

  • Antitubercular Agents
  • DNA, Ribosomal Spacer
  • RNA, Ribosomal, 16S
  • RNA, Ribosomal, 23S

Associated data

  • GENBANK/DQ067465
  • GENBANK/DQ185131